Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sack

Showing results (171-180 of 245) with videos related to

Pageof 25
Sort By:
Journal of Molecular Biology|February 10, 1995
Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombinL Tabernero, C Y Chang, S L Ohringer, et al.
Cancer|November 15, 2022
Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical courseAneesha Haryal, Matthew J Townsend, Vinitha Baskaran, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases: highly potent 2,6-Difluorophenacyl analoguesRaj N Misra, Hai yun Xiao, David B Rawlins, et al.
Acta Crystallographica. Section D, Biological Crystallography|May 1, 1996
Crystallization and preliminary crystallographic analysis of E. coli uridine 5'-diphospho-N-acetylenolpyruvylglucosamine reductase in two new crystal formsS L Ohringer, C Y Chang, S Sheriff, et al.
Journal of Pediatric Urology|July 4, 2020
Evaluation of outcomes following complete primary repair of bladder exstrophy at three individual sites prior to the establishment of a multi-institutional collaborative modelDana A Weiss, Aseem R Shukla, Joseph G Borer, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2017
Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitorsRajeev S Bhide, Alec Keon, Carolyn Weigelt, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinasesRaj N Misra, David B Rawlins, Hai-yun Xiao, et al.
The Biochemical Journal|March 18, 2011
Structural basis for CARM1 inhibition by indole and pyrazole inhibitorsJohn S Sack, Sandrine Thieffine, Tiziano Bandiera, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2001
Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosteroneJ S Sack, K F Kish, C Wang, et al.
Journal of Pediatric Urology|July 22, 2023
The role of a photographic atlas in reducing unanticipated healthcare utilization following circumcisionC A Ferreri, A Benvenuto, D E Cassidy, et al.
Pageof 25

Showing results (171-180 of 245) with videos related to

Sort By:
Pageof 25
Journal of Molecular Biology|February 10, 1995
Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombinL Tabernero, C Y Chang, S L Ohringer, et al.
Cancer|November 15, 2022
Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical courseAneesha Haryal, Matthew J Townsend, Vinitha Baskaran, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases: highly potent 2,6-Difluorophenacyl analoguesRaj N Misra, Hai yun Xiao, David B Rawlins, et al.
Acta Crystallographica. Section D, Biological Crystallography|May 1, 1996
Crystallization and preliminary crystallographic analysis of E. coli uridine 5'-diphospho-N-acetylenolpyruvylglucosamine reductase in two new crystal formsS L Ohringer, C Y Chang, S Sheriff, et al.
Journal of Pediatric Urology|July 4, 2020
Evaluation of outcomes following complete primary repair of bladder exstrophy at three individual sites prior to the establishment of a multi-institutional collaborative modelDana A Weiss, Aseem R Shukla, Joseph G Borer, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2017
Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitorsRajeev S Bhide, Alec Keon, Carolyn Weigelt, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinasesRaj N Misra, David B Rawlins, Hai-yun Xiao, et al.
The Biochemical Journal|March 18, 2011
Structural basis for CARM1 inhibition by indole and pyrazole inhibitorsJohn S Sack, Sandrine Thieffine, Tiziano Bandiera, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2001
Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosteroneJ S Sack, K F Kish, C Wang, et al.
Journal of Pediatric Urology|July 22, 2023
The role of a photographic atlas in reducing unanticipated healthcare utilization following circumcisionC A Ferreri, A Benvenuto, D E Cassidy, et al.
Pageof 25